Vincent Keating, MD
Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1871569103
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $73,750 of the $80,063 with a category attached, or 92.1%. Boston Scientific accounts for 94.0% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $58,243, more than ten times the $919 reported in 2019. Among clinical cardiac electrophysiology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $236.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$75K
- Medtronic$984
- Abbott$667
- Biotronik Inc.$647
- Novartis$617
- Johnson & Johnson$314
- plus $2K from 27 others
What the payments were for
- Consulting fees$4000%
- Speaking & faculty fees$73,75092%
- Travel & lodging$1670%
- Food & beverage$5,6907%
- Education$570%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 127 | $75,256 |
| Medtronic(2 entities) | 18 | $984 |
| Abbott | 37 | $667 |
| Biotronik Inc. | 7 | $647 |
| Novartis | 44 | $617 |
| Johnson & Johnson | 20 | $314 |
| Pfizer | 16 | $260 |
| Philips North America LLC | 3 | $160 |
| Novo Nordisk | 7 | $148 |
| AstraZeneca | 7 | $135 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $122 |
| Sanofi-aventis U.S. LLC | 7 | $96 |
| Kestra Medical Technology Services, Inc. | 5 | $95 |
| Atricure, Inc. | 3 | $70 |
| Merck | 4 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Amgen | 3 | $39 |
| Boehringer Ingelheim | 2 | $29 |
| Bayer | 2 | $28 |
| Teleflex LLC | 1 | $26 |
| Angiodynamics, Inc. | 1 | $23 |
| Cardiofocus, Inc. | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $18 |
| Altathera Pharmaceuticals LLC | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Vifor Pharma, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Elutia, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$57,500
- Edora 8 DR-T$400
- Micra$289
- Rhythmia Mapping System$165
- PulseSelect$161
- SelectSecure$160
- ENSITE PRECISION$151
- (9520) IGT Devices Undivided$123
- GENERAL TACHY$117
- ARCTIC FRONT ADVANCE$115
- WATCHMAN Access System$109
How this compares
$80,063 in reported general payments places this provider in the 90th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 647 | $662,392 |
| XareltoRivaroxaban | 141 | $143,413 |
| EntrestoSacubitril/Valsartan | 47 | $42,391 |
| Dofetilide | 143 | $28,987 |
| SavaysaEdoxaban Tosylate | 13 | $5,420 |
| SotalolSotalol Hcl | 195 | $4,749 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 17 | $3,773 |
| Metoprolol Succinate | 235 | $3,175 |
| Flecainide Acetate | 67 | $2,658 |
| Amiodarone Hcl | 102 | $2,157 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 55 | $1,462 |
| Potassium Chloride | 27 | $1,116 |
| Warfarin Sodium | 82 | $690 |
| Carvedilol | 50 | $355 |
| Metoprolol Tartrate | 57 | $320 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $260 | $662,392647 claims |
| Johnson & JohnsonXarelto | $314 | $143,413141 claims |
| NovartisEntresto | $617 | $42,39147 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Indianapolis
- Eric PrystowskyIndianapolis$1.1M
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
- Christopher ReedIndianapolis$80K
- Marcelle StuckyIndianapolis$76K
- Joseph SzwedIndianapolis$67K
- Krishna MalineniIndianapolis$65K
- Anil PurohitIndianapolis$45K
- Bradley ClarkIndianapolis$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.